For more information, call Erica C. Cline at 706/828-2225.
Diabetes Drug Avandia Scrutinized by Food and Drug Administration
AUGUSTA, GA (July 12, 2010) – The popular diabetes drug Avandia is back in the news as the U.S. Food and Drug Administration takes another look at the drug to determine whether it should be pulled from the shelves.
The drug, which helps treat insulin resistance in people with diabetes, is now thought to increase the risk of heart attack in some people.
Ian Herskowitz, M.D., a medical endocrinologist who practices at University Hospital, said there are certain populations that should avoid the drug.
"Basically, the drug should not be taken by diabetics who might have an underlying heart condition -- particularly heart failure," he said. "People on insulin also should avoid it."
Avandia was first targeted by the FDA in 2007 after dozens of studies linked the drug to heart attacks. Later that year the FDA added a warning label to the drug.
If you are taking Avandia, Dr. Herskowitz recommended contacting your physician to determine if you should stop taking the drug.